tabcin
- Product NDC
- 69729-836
- Requested package NDC
- 69729-836-20
- 11-digit product format
- 697290836
- Labeler code
- 69729
- Product ID
- 69729-836_5d5cf5fa-cdc5-563e-e063-6294a90aee3a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dextromethorphan HBr, Guaifenesin
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- OPMX LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-09-07
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 20; 400 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- tabcin
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 20 mg/1 |
| GUAIFENESIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1661740 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 23223821-4fa0-5d99-e063-6394a90af0e5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex Severe All in One Sinus | ACETAMINOPHEN, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | 9a106398-6d9d-2146-e053-2995a90a3fdf | 2026-10-02 | Warnings | M012 |
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 4644c4ae-9607-d404-e063-6294a90aca24 | 2026-10-02 | Warnings | M012 |
| VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | 4645336e-40d8-89e6-e063-6294a90a7655 | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464534ee-15f8-3af8-e063-6394a90a3f18 | 2026-10-02 | Warnings | M012 |
| Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464550b3-5970-aca5-e063-6294a90a5954 | 2026-10-02 | Warnings | M012 |
| Vicks Jarabe Cough Congestion | DEXTROMETHORPHAN HBR AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | a0fa86d4-e53b-cbf4-e053-2995a90a1396 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Cough DM plus Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | c48359ee-6e52-841d-e053-2a95a90ae293 | 2026-10-02 | Warnings | M012 |
| NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | ef6df67c-0afa-4825-e053-2995a90aced9 | 2026-10-02 | Warnings | M012 |
| DayQuil and NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fbd53e5f-bc03-75b4-e053-6394a90af028 | 2026-10-02 | Warnings | M012 |
| DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | ef6e8503-d268-291b-e053-2995a90aec8f | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fd03769c-2fd6-1c22-e053-6394a90a12f6 | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04c9ccda-64aa-0cd0-e063-6394a90a32bf | 2026-10-02 | Warnings | M012 |
| VICKS NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04ca1e9c-f297-cbd6-e063-6294a90a3739 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 1b579102-9eac-1b2f-e063-6394a90add0a | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | d3b2ca47-d51e-f69f-e053-2995a90a587e | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil NyQuil SEVERE HONEY COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 25a092c3-a9cb-6314-e063-6294a90a5297 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Procter & Gamble Manufactura S de RL de CV | 424cf178-39cc-b37c-e063-6394a90a990b | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 4535d4fe-9de7-f2c6-e063-6394a90a944a | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 457180c9-87ea-5b52-e063-6294a90a7e9d | 2026-10-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1661740 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Capsule | PSN | 23223821-4fa0-5d99-e063-6394a90af0e5 | 2 |
| 1661740 | dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Capsule | SCD | 23223821-4fa0-5d99-e063-6394a90af0e5 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69729-836-20 | 69729083620 | 1 BLISTER PACK in 1 CARTON (69729-836-20) / 20 CAPSULE, LIQUID FILLED in 1 BLISTER PACK | 1 blister pack | 2026-09-07 | No | No | Current |